US FDA approves first generic version of Plan B for women aged 17 and younger
This article was originally published in SRA
The US Food and Drug Administration has approved the first generic version of the emergency contraceptive drug, Plan B (levonorgestrel)1,2. The move comes shortly after the FDA gave up its lengthy and controversial battle to restrict non-prescription access to the product.
You may also be interested in...
Companies are being encouraged to become “early adopters” of the EU Clinical Trials Information System when it goes live in December 2021.
Drug companies will be able to “play around” with the new EU Clinical Trials Information System in a secure testing environment before it goes live in approximately 15 months.
The Canadian authorities have put in place an expedited pathway for authorizing new COVID-19 drugs and vaccines that offers a more agile approach to reviewing data than what was previously allowed.